JPRN-jRCT2080222215未知1 期
Phase I clinical trial of TO-206 - Safety trial in patients with Japanese cedar pollinosis
适应症
试验速览
- 阶段
- 1 期
- 入组人数
- 70
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 <= 49age old（—）
- 性别
- Male
入选标准
- •1)Patients with specific IgE against cedar pollen CAP class 3 or more
- •2)Positive skin prick test against cedar pollen
- •3)Patients who have a clinical history of cedar pollinosis in 2012 and 2013 cedar pollen seasons
排除标准
- •1)Patients with perennial allergic rhinitis, medication-derived rhinitis, vasomotor rhinitis or non-allergic rhinitis during therapy
- •2)Patients who have developed asthmatic attack within 5 years before the pre-treatment observation visit
- •3)Patients who have received specific immunotherapy for cedar pollinosis in history
研究者
相似试验
未知
1 期
Phase I Clinical Trial of TO-203 - Safety Trial in Patients with HDM (House Dust Mite)-induced AsthmaHDM-induced asthmaJPRN-jRCT2080221584TORII PHARMACEUTICAL CO., LTD.48
尚未招募
不适用
A phase I clinical trial to study the safety of treatment with Tipifarnib (ZARNESTRA) combined with Bortezomib (VELCADE) in patients with myelodysplastic syndrome (MDS)myelodysplasiamyelodysplastic syndroom10018865NL-OMON30154niversitair Medisch Centrum Sint Radboud18
招募中
1 期
Phase I study for the efficacy and the safety of the perioperative urinastatin therapy in chest surgical patients with interstitial pneumonia.interstitial pneumonia, lung cancer, metastatic lung tumor, pneumothoraxJPRN-UMIN000003295Tokyo Women's Medical University of Medicine, Department of Surgery I30
已完成
1 期
Mesenchymal Stem Cells Transplantation in newly diagnosed Type-1 Diabetes PatientsDiabetes.Insulin-dependent diabetes mellitusIRCT2016070428786N1Royan Institute20
招募中
不适用
To Assess the Safety and Pharmacokinetic Profile of CKD-516 inj. Administered on A Twice-Weekly Schedule in Patients with Advanced Solid Cancers Failed to Standard TherapyNeoplasmsKCT0000499Chong Kun Dang24